Amphastar Pharmaceuticals Inc (AMPH)
EBITDA Growth
-0.31%
Quarterly · Period ending:
AMPH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-0.31%period ending
Latest reported-0.31%period ending
AMPH Quarterly EBITDA YoY % (-32.23% → -0.31%)
Year-over-year change
High-resolution chart · PNG
AMPH ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -0.3104% | |
| -36.7835% | |
| -16.1719% | |
| -39.0734% | |
| -15.2636% | |
| -25.0755% | |
| 0.7137% | |
| -24.3054% | |
| 68.0758% | |
| 68.936% | |
| 31.2218% | |
| 198.1927% | |
| 42.9733% | |
| 14.3161% | |
| 45.2791% | |
| -31.7705% | |
| 43.4976% | |
| 200.4484% | |
| 29,107.7586% | |
| 220.9294% | |
| 375.8148% | |
| 2.9052% | |
| -98.3085% | |
| 81.5491% | |
| -33.4181% | |
| 1,179.0164% | |
| 15.7468% | |
| 12.5642% | |
| 8,809.3333% | |
| 118.0047% | |
| 98.0281% | |
| 220.3103% | |
| -98.9655% | |
| -296.8242% | |
| 523.796% | |
| -77.6388% | |
| -48.0175% | |
| -67.3289% | |
| -104.018% | |
| 2,596.5879% | |
| 304.2918% | |
| 403.4946% | |
| 654.2902% | |
| 89.9737% | |
| -363.6925% | |
| -261.7391% | |
| -148.6868% | |
| -208.5094% | |
| -83.2579% | |
| -70.9124% | |
| -32.2336% |